Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study

INTRODUCTION: This study aimed to estimate risks of cardiovascular and cerebrovascular events in patients treated with lisdexamfetamine dimesylate (LDX) compared with patients previously treated with other attention-deficit/hyperactivity disorder (ADHD) medications (amphetamine, dexamphetamine, meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Forns, Joan, Dudukina, Elena, Hägg, David, Szentkúti, Péter, Gembert, Karin, Plana, Estel, Gilsenan, Alicia, Horváth-Puhó, Erzsébet, Ehrenstein, Vera, Reutfors, Johan, Rebordosa, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588134/
https://www.ncbi.nlm.nih.gov/pubmed/36028603
http://dx.doi.org/10.1007/s40120-022-00396-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588134/
https://www.ncbi.nlm.nih.gov/pubmed/36028603
http://dx.doi.org/10.1007/s40120-022-00396-y

Ejemplares similares